Upper Extremity Lymphatic Mapping for Breast Cancer Patients: A Pilot Study
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Number and prevalence of metastases of blue nodes in the ALND specimen (nodes draining the breast).
conclusion of the study
Leslie Montgomery, MD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan Kettering Cancer Center||New York, New York 10021|